Advertisement

Drugs - Real World Outcomes

, Volume 3, Issue 1, pp 13–24 | Cite as

Medicines Management, Medication Errors and Adverse Medication Events in Older People Referred to a Community Nursing Service: A Retrospective Observational Study

  • Rohan A. Elliott
  • Cik Yin Lee
  • Christine Beanland
  • Krishna Vakil
  • Dianne Goeman
Open Access
Short Communication

Abstract

Background

Increasing numbers of older people are receiving support with medicines management from community nursing services (CNSs) to enable them to live in their own homes. Little is known about these people and the support they receive.

Objectives

To explore the characteristics of older people referred for medicines management support, type of support provided, medication errors and adverse medication events (AMEs).

Methods

A retrospective observational study of a random sample of 100 older people referred to a large non-profit CNS for medicines management support over a 3-month period was conducted. Measures were: demographics, referral source, current medical problems, medicines, medication aids, types of medication authorisations used by nurses, frequency of nurse visits and type of support provided, medication errors, AMEs and interdisciplinary teamwork among community nurses, general practitioners and pharmacists.

Results

Older people (median 80 years) were referred for medicines support most often by hospitals (39 %). Other referrals were from families/carers, case-managers, palliative care services and general practitioners. Multiple health conditions (median 5) and medicines (median 10) were common; 66 % used ≥5 medicines; 48 % used ≥1 high-risk medicines—most commonly opiates, anticoagulants and insulin. Medication aids were frequently used, mostly multi-compartment dose administration aids (47 %). Most people received regular community nurse visits (≥4 per week) to administer medicines or monitor medicine-taking. Only 16 % had a medication administration chart; for other clients nurses used medicine lists or letters from doctors for medication authorisation. Medication errors occurred in 41 % of people and 13 % had ≥1 AME requiring medical consultation or hospitalisation; 9/13 (64 %) AMEs were potentially preventable. There was little evidence of interdisciplinary teamwork or medication review.

Conclusion

CNS clients had multiple risk-factors for medication misadventure. Deficiencies in medicines management were identified, including low use of medication charts and interdisciplinary medication review. Strategies are needed to improve medicines management in the home-care setting.

Keywords

Medication Error Medication Reconciliation Medicine Management Home Medicine Review Adverse Medication Event 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Key Points

Older people referred to a community nursing service (CNS) for support with medicines management received intensive assistance, often over a prolonged period; they had multiple risk-factors for adverse medication events but interdisciplinary collaboration and medication review was uncommon.

Medication errors and adverse medication events requiring medical consultation occurred in 41 and 13 % of CNS clients respectively; a majority of adverse medication events were preventable.

There is a need to develop and test strategies to improve medication safety for CNS clients.

1 Introduction

The number of older Australians has increased by 65 % over the last 20 years [1]. Over the same period there has been a growing focus on supporting older people to remain living in their own homes for as long as possible [2], and an increase in the intensity of treatment for medical conditions that commonly affect older people (such as cardiovascular disease, diabetes, osteoporosis), leading to increased polypharmacy and medication regimen complexity [3]. Together these factors have led to increased demand for community nursing services (CNSs) to support older people with managing medicines at home [4]. A large Australian CNS recently reported that 56 % of its home nursing visits were primarily for the purpose of supporting medicines management [5]. Similar trends have been reported internationally [6].

There is evidence that older people receiving home nursing care are a group at high risk of medication-related problems and adverse medication events (AMEs) [7, 8, 9, 10]. It has been suggested that the risk of medication-related problems among CNS clients may be greater than in other healthcare settings such as hospitals and residential aged-care facilities because of the unstructured environment and communication challenges in the home care setting [11]. For example, home care nurses have a less direct relationship and less contact with clients’ medical practitioners and pharmacies. There may be multiple prescribers and multiple pharmacies involved in the client’s care. Prescribers and pharmacists may not see the client regularly and may rely on the nurse to report medication-related problems. Home-care clients and their informal carers often participate in their own medicines management (by self-administering some medicines, attending medical appointments, purchasing over-the-counter medicines, etc.) which means there is potential for non-adherence and medication self-administration errors [11, 12].

Despite large numbers of people receiving CNS support, there has been little research focusing on this group [12, 13]. In Australia, Johnson et al. used a convenience sample of 111 CNS clients to develop medication risk assessment criteria and test a nurse-led intervention to improve medicine use [7, 14], and While et al. [15, 16, 17] conducted a series of qualitative studies exploring issues related to medicines management in CNS clients and their carers. Whilst these studies, and similar studies from other countries [9, 10, 12], highlighted complexities and problems related to medicines management, they did not recruit representative samples of CNS clients or report the frequency or type of medicines management support provided or the prevalence of medication errors and AMEs. Knowing more about people who receive medicines management support from CNSs, the types of support they receive and medication-related problems and AMEs encountered, may help with identifying areas for improvement and planning future care needs for home-care clients.

The aim of this study was to describe the characteristics of community-dwelling older people referred to an Australian CNS for support with medicines management, their medicines management and medication errors and adverse medication events.

2 Methods

2.1 Setting

The study was conducted at two metropolitan sites of a large, not-for profit CNS in Melbourne, Australia. The sites employed 120 registered nurses (degree-qualified nurses), nine enrolled nurses (diploma- or certificate-qualified nurses) and eight community care aides (non-nurse professional care workers).

2.2 Subjects

One hundred CNS clients were randomly selected (using a random number generator) from all people aged 50 years and over who were referred for medicines support between 16 July and 12 October 2012.

2.3 Data Collection

Data were collected (May–December 2013) by retrospective review of clients’ CNS records and telephone contact with clients’ general practitioners (GPs) and pharmacies, using a pre-piloted data collection form. Data collected, and definitions, are provided in Table 1.
Table 1

Data collected and definitions

Data (definition)

 Source of referral to the CNS

 Reason for referral to the CNS

 Current medical problems (active medical problems at the time of admission to the CNS)

 Presence of cognitive impairment (documented dementia or mild cognitive impairment, Mini-Mental State Examination score <24 or Rowland Universal Dementia Assessment Scale score <23)

 Medicines used at the time of CNS admission (medicines listed on the clients’ first ‘medication authorisation’)

 Use of medicines associated with heightened risk of an adverse medication event if taken or administered incorrectly (high risk: anticoagulants, chemotherapeutic agents excluding hormonal agents, immunosuppressant agents, insulins, lithium, opioids; moderate risk: antibiotics, anticonvulsants, antipsychotics, benzodiazepines, loop diuretics, oral corticosteroids, oral hypogylcaemics) [42]

 Medication management aids used (e.g. dose administration/adherence aids)

 CNS visits in the first and last weeks of the CNS admissiona

 Types of medication authorisations (medication administration charts or other medicine lists or instructions signed by a medical practitioner authorising the CNS to administer medicines or support clients’ medicine self-administration) used during first and last weeks of admissiona

 Medication errors (deviations from the prescriber’s instructions, whether or not they led to harm)

 Adverse medication events (adverse drug reactions [ADRs] requiring medical consultation and unplanned medication-related hospital admissions)

 Evidence of interdisciplinary teamwork (documented communication between CNS staff and prescribers or pharmacists, Home Medicines Reviews,b Team Care Arrangements,c Case Conferencesd)

 Duration of CNS care (number of days from CNS admission to CNS discharge)e

 Discharge location

CNS community nursing service

aFor clients who had not been discharged from the CNS at the time of the audit, the last week of admission for the purpose of data collection was taken to be the last week of available data (at least six months after admission to the CNS)

bHome Medicines Review (HMR) is an Australian Government funded program that is available to patients in the community setting who are at risk of adverse medication events. A general practitioner can initiate an HMR by making a referral to an accredited consultant pharmacist

cTeam Care Arrangement is an Australian Government funded (Medicare) service in which a general practitioner works with other health professionals involved in a patient’s management to prepare and implement a multidisciplinary care plan

dCase conference is an Australian Government funded (Medicare) service in which a general practitioner organises, coordinates or participates in a meeting or discussion held to ensure that their patient’s multidisciplinary care needs are met through a planned and coordinated approach

eCNS episodes of care that were temporarily interrupted by a period of residential respite or an acute hospitalisation were counted as one episode of care

Referral details, medical problems, cognitive function and use of medication aids were obtained from referral documents, CNS admission notes and care plans. Medicines used by clients were obtained from medication authorisations.

CNS home visits, medication errors, AMEs and discharge location were identified by reviewing CNS progress notes and discharge records. Evidence of interdisciplinary teamwork was identified from CNS records and telephone calls to clients’ GPs and/or community pharmacies.

2.4 Data Analysis

Age-adjusted Charlson Co-morbidity Index scores were calculated (a score of ≥ 5 indicates at high risk of mortality) [18]. The use of medicines associated with heightened risk of adverse events was determined by a pharmacist researcher, who compared clients’ medicine lists against a pre-defined list of ‘risk’ medicines (Table 1).

Potential AMEs were reviewed by an expert panel to determine causality, preventability and contribution to hospital admission, using modified Hallas criteria [19, 20]. The panel comprised three clinical pharmacists and two registered nurses, each with over 15 years of experience encompassing hospital and community aged care. Panel members assessed each case independently. When there was disagreement, the case was discussed until consensus was reached. Severity was assessed using Pearson criteria [21], and the primary underlying cause of the AME was classified using Hepler and Strand’s classification [22]. The AME assessment criteria are provided in Supplementary File 1.

Data were analysed using SPSS (version 21, IBM Corporation, USA). Analyses were carried out using descriptive tests, with results reported as frequency and proportion for categorical variables and median and interquartile range (IQR) for discrete and non-normally distributed continuous variables.

3 Results

One hundred and ninety-seven people aged 50 years or over were referred for medicines support. The characteristics of the 100 clients selected for the study, and their reasons for referral, are summarised in Table 2. CNS clients were visited a median of four to five days a week. In the first week of care the most common reason for medicines support visits was to administer medicines; in the last week it was to monitor medicine-taking (Table 3).
Table 2

Client characteristics and medicines management (n = 100 clients)

Variable

Data

n (%) or median (IQR); range

Age, years

80 (73–87); 55–97

Gender female, n (%)

60 (60 %)

No. of current medical conditions

5 (3–7); 1–22

Type of medical conditionsa

 Cancer, leukemia, lymphoma (excluding skin cancer)

32 (32 %)

 Diabetes

32 (32 %)

 Respiratory disease

17 (17 %)

 Dementia or Alzheimer’s disease

16 (16 %)

 Myocardial infarction

15 (15 %)

 Cerebrovascular accident

14 (14 %)

 Renal disease

11 (11 %)

 Congestive heart failure

8 (8 %)

 Others

8 (8 %)

Age-adjusted Charlson Comorbidity Index score

6 (5–8); 1–13

 Charlson score ≥5 (higher risk of mortality)

77 (77 %)

Cognitive impairmentb

30 (30 %)

Number of medicinesc

10 (6–13); 2–26

Reason for referral to CNS

 

 Medicines management ONLYd

81 (81 %)

 Medicines management plus OTHER caree

19 (19 %)

Source of referral to CNS

 Hospital

39 (39 %)

 Family or informal carer

12 (12 %)

 Palliative care service

12 (12 %)

 Case manager

11 (11 %)

 General practitioner

10 (10 %)

 Aged Care Assessment Team

6 (6 %)

 Medical specialist

3 (3 %)

 Community health service

2 (2 %)

 Self

1 (1 %)

 Unknown

4

Duration of care (length of stay) with CNS

 1–7 days

25 (25 %)

 8–30 days

29 (29 %)

 31–60 days

21 (21 %)

 >60 days

25 (25 %)

Discharge location

 Home

56 (56 %)

  With self-care or informal care

41

  Client terminated care

4

  With other formal care

2

  Ongoing care not documented

9

 Acute hospital

20 (20 %)

 Subacute or palliative care hospital

5 (5 %)

 Residential care

9 (9 %)

 Died at home

8 (8 %)

 Unknown

2 (2 %)

Multi-compartment dose administration aid (DAA)

47 (47 %)f

 DAA packed by

 

  Community pharmacy

42

  Client/carer/family member

2

  Not documented

3

Single-compartment DAA used by CNS for setting out evening doses when nurse visited in the morning

12 (12 %)

Locked box used by CNS to store medicines

17 (17 %)g

CNS community nursing service, DAA Dose Administration Aid

aConditions included in the Charlson Comorbidity Index

bLikely to be an underestimate, because only 36 % clients had a MMSE or RUDAS score documented

cNumber of medicines at the time of admission to RDNS (includes regular and when required medicines; when combination products were used the individual active ingredients were counted as separate medicines). Data not available for 15 clients

dMonitoring medicine-taking, administering medicines, medicines prompting and assisting with self-administration

eWound care (n = 14), personal care such as hygiene or mobility assistance (n = 7), clinical monitoring such as blood pressure, weight, bowel function, pain, fluids (n = 7)

f20/47 (42.6 %) clients using a multi-compartment DAA received CNS visits 7 days a week

g11/47 (23.4 %) clients using a multi-compartment DAA had a locked box used to store the medicines

Table 3

Community nursing service (CNS) visits

 

First week of care (100 clients)

n (%) clients

Last week of care (71 clients)a

n (%) clients

No. of days per week that CNS visited clients

 1 to 2

19 (19.0 %)

28 (39.4 %)

 3 to 4

23 (23.0 %)

8 (11.2 %)

 5 to 6

19 (19.0 %)

14 (19.8 %)

 7

39 (39.0 %)

21 (29.6 %)

 Median

5 (IQR 3–7, range 1–7)

4 (IQR 2–7, range 1–7)

No. of times CNS visited per day

 1

87 (87.0 %)

64 (90.1 %)

 2

9 (9.0 %)

5 (7.0 %)

 3

4 (4.0 %)

2 (2.8 %)

Primary reason for CNS medicines support visits (as per care plan)

  

 Administering medicines

44 (44 %)

27 (38.0 %)

 Monitoring medicine-taking

32 (32 %)b

28 (39.4 %)

 Assisting with medicine-taking

16 (16 %)

7 (9.9 %)

 Prompting medicine-taking

8 (8.0 %)

6 (8.5 %)

 Other

3 (4.2 %)c

Type of medicine support provided by CNS (as per progress notes)d

 Assessment of medicines management

14 (14 %)

1 (1.4 %)

 Administering medicines

52 (52 %)

32 (45.1 %)

 Monitoring medicine-taking

55 (55 %)

39 (54.9 %)

 Assisting with medicine-taking

32 (32 %)

19 (26.8 %)

 Prompting medicine-taking

16 (16 %)

12 (16.9 %)

 Education about medicines management

20 (20 %)

3 (4.2 %)

 Liaising with community pharmacy or doctors about clients’ medicines

8 (8 %)

1 (1.4 %)

Medicines support provided for

 All prescribed medicines

50 (50 %)

40 (56.3 %)

 Selected medicinese

48 (48 %)

26 (36.6 %)

 Not documented

2 (2.0 %)

5 (5.0 %)

aLast week data only includes clients whose length of stay with CNS was ≥14 days

bSometimes combined with education (e.g. education and monitoring for clients newly commenced on insulin)

cNo longer needing medicines management support in final week of care, but still receiving other care (monitoring blood sugar level n = 1; wound care n = 2)

dMost clients had more than one type of medicines support documented

eSome clients self-administered most of their medicines but required support with particular medicines such as injectable medicines, warfarin, eye drops

A minority of clients (n = 16) had a medication administration chart during the first week of their CNS admission; 14 of these were handwritten by a hospital doctor and two were printed or handwritten by a GP. The remaining 84 clients’ treatment authorisations were printed or handwritten medicine lists provided by the client’s GP (n = 48), hospital doctor (n = 27), specialist (n = 1) or unknown source (n = 8). Use of medication administration charts remained low, with only 15 clients having one at the time of discharge. Twenty-two clients had more than one medication authorisation used concurrently (e.g. a GP medicine list plus a letter from a GP or specialist indicating a medicine change) during either the first or last week of their CNS admission.

Medication authorisations for 85 clients included all of their medicines. The other 15 clients’ authorisations included a partial list only (usually parenteral medicines, because the CNS was involved in administering those medicines only). The 85 clients with a complete medicine list used a median of ten medicines (IQR 6–13, range 2–26), and 66 % used five or more. The median number of regular, long-term medicines (excluding ‘when required’ and short-term medicines) was eight (IQR 4–11, range 1–21). Forty-eight clients used one or more high risk medicines, most commonly opiates (28 % clients), anticoagulants (17 % clients) and insulins (14 % clients).

One hundred and thirty-seven medication errors were identified, affecting 41 (41 %) clients (Table 4). Twenty-three (23 %) clients had an unplanned hospital admission—after expert panel review 9/23 (39.1 %) of these were deemed to have been possibly medication-related (Table 5). Five clients had an ADR that required medical consultation without hospital admission. One client had both a medication-related hospital admission and an ADR without admission, so overall there were 13 (13 %) clients with one or more AME requiring medical consultation or hospitalisation (Table 5). Nine (64 %) AMEs were considered to have been potentially preventable. Eight clients died at home; all were receiving end-of-life care for a terminal illness prior to their death.
Table 4

Medication errors (n = 100 clients)

Variable

Data

n (%) or median (IQR); range

Clients with one or more medication error

41 (41 %)

Number of errors identified

137

No. of medication errors per client

 1

14

 2

10

 3 or more

17

Type of medication errors

 Missed dose

67 (48.9 %)

 Discrepancy between medication authorisation and client’s medicines

26 (19.0 %)a

 Wrong dose taken/given

13 (9.5 %)

 Medicine taken from wrong compartment of DAA

12 (8.8 %)

 Extra dose taken/given

15 (10.9 %)

 Wrong administration method

2 (1.5 %)

 Wrong route of administration

1 (0.7 %)

 Wrong dose time

1 (0.7 %)

Errors involving high-risk medicines

 Opiates

10

 Insulins

5

 Anticoagulants

3

 Immunosuppressants

3

 Lithium

1

 Total

22/137 (16.1 %)

Errors involving moderate-risk medicines

 Oral hypogylcaemics

6

 Benzodiazepines

6

 Loop diuretics

4

 Anticonvulsants

4

 Antipsychotics

3

 Oral corticosteroids

2

 Antibiotics

1

 Total

23 (16.8 %)

Causes of error(s)

 Client/carerb

101 (73.7 %)

 Healthcare provider/systemc

36 (26.3 %)

DAA dose administration aid

aIn 22 cases the discrepancy involved a pharmacy-packed DAA

bClient/carer errors (e.g. forgot to take medicine, accidentally took wrong dose, dropped tablet on the floor) or deliberate non-adherence (e.g. chose not to take a medicine or varied the dose). It was not possible to accurately quantify what proportion were unintended errors versus deliberate non-adherence using retrospective methodology; however, a large majority appeared to be errors

cErrors caused by general practitioners and other prescribers, pharmacists and nurses. This includes prescribing errors, dispensing errors, administration errors and communication failures. The number of errors attributed to each of these categories could not be accurately quantified retrospectively, because often the specific cause could not be determined. For example, when there was a discrepancy between the medication authorisation and the client’s medicines (n = 26), it was not possible to determine whether this was due to an error on the authorisation, a dispensing/DAA packing error, or lack of communication between members of the healthcare team following a medicine change. Other provider/system errors were: medicines not available (not re-ordered or not delivered by pharmacy) (n = 3), multiple DAAs delivered resulting in client confusion and error (n = 3), patch not removed when new one applied (n = 1), problem with syringe driver (n = 1), delayed nurse visit (n = 1)

Table 5

Adverse medication events (AMEs)

Patient

AME

Medicine(s)

Underlying cause of AME

Causality

Preventability

Severity

Contribution to hospital admission

Events requiring medical consultation but no hospital admission

 72 years female with dementia

Nausea and vomiting

Donpezil 5 mg daily (recently commenced)

Idiosyncratic response

Probable

Not preventable

Mild

 88 years male with dementia

Fatigue

Rivastigmine 9 mg patch daily (recently commenced)

Idiosyncratic response

Possible

Not preventable

Mild

 86 years female with deep vein thrombosis

Bruising

Warfarin 3 mg daily (recently commenced; 5 mg taken by client inadvertently on one occasion). Also on aspirin 100 mg daily

Patient-related/Prescribing issue

Probable

Possibly preventable

Mild

 92 years female with atrial fibrillation, congestive cardiac failure and renal impairment

Bradycardia

Digoxin 187.5 µg daily

Prescribing issue

Probable

Definitely preventable

Moderate

 80 years male with type 2 diabetes, discharged from hospital on a short course of prednisolone

Hypoglycaemia

Lantus (insulin) 22 units daily (recently commenced in hospital), gliclazide MR 120 mg daily, weaning prednisolone dose

Prescribing issue

Definite

Definitely preventable

Moderate

Events that contributed to an unplanned hospital admission

 68 years female with breast cancer

Erythema multiforme

Docetaxel (administered in hospital, but reaction occurred at home)

Idiosyncratic response

Definite

Not preventable

Moderate

Dominant

 77 years female with recent major abdominal surgery

Urethral bleed

Enoxaparin 40 mg subcut daily

Idiosyncratic response

Probable

Not preventable

Moderate

Partly contributing

 89 years female with multiple co-morbidities

Fall, fractured neck of femur

Polypharmacy (15 regular medicines), including fall-risk increasing medicines (diazepam 5 mg at night, cyproheptadine 4 mg daily, amlodipine 10 mg daily, irbesartan 300 mg/hydrochlorothiazide 12.5 mg daily, atenolol 50 mg daily, carbamazepine 200 mg at night)

Prescribing issue

Possible

Possibly preventable

Severe

Dominant

 74 years female with anxiety disorder discharged from hospital psychiatric unit

Exacerbation of anxiety disorder

Abrupt cessation of quetiapine 75 mg/day (ceased by general practitioner).

Prescribing issue

Probable

Possibly preventable

Moderate

Dominant

 89 years female with multiple co-morbidities

Fall, fractured neck of femur

Polypharmacy (5 regular medicines), including fall-risk increasing medicines (citalopram 20 mg daily, dipyridamole SR 200 mg daily, amlodipine 5 mg daily, trandolapril 1 mg daily)

Prescribing issue

Possible

Possibly preventable

Severe

Dominant

 92 years female with atrial fibrillation and congestive cardiac failure

Severe peripheral oedema and skin tear

Frusemide 20 mg/day (no dose increase despite increasing oedema). Digoxin recently ceased. Also on bisoprolol 2.5 mg daily, telmisartan 80 mg daily

Prescribing issue

Possible

Possibly preventable

Moderate

Partly contributing

 68 years female with metastatic breast cancer

Pain crisis

Suspected non-adherence to oral analgesia

Patient-related issue

Probable

Definitely preventable

Moderate

Dominant

 87 years female with metastatic adenocarcinoma

Pain/end of life care

Morphine 5–10 mg, midazolam 0.5–2.0 mg and metoclopramide 10–40 mg subcut infusion (faulty syringe driver resulting in inadequate therapy)

Delivery issue

Probable

Possibly preventable

Moderate

Dominant

 91 years female with hypertension

Dehydration and hyponatraemia

Irbesartan with hydrochlorothiazide 300 mg/12.5 mg daily

Idiosyncratic response

Possible

Not preventable

Moderate

Dominant

The criteria used to determine adverse medication event causality, preventability, severity and contribution to hospital admission are provided in Supplementary File 1

There was little evidence of interdisciplinary teamwork. CNS nurses recorded contact with the clients’ GP or pharmacy for only eight clients in the first week of care and one in the final week. No client had a multidisciplinary case conference documented at any time during their CNS admission, and only one client had a Team Care Arrangement. One client had a Home Medicines Review (HMR) recorded in their CNS record; a further four had received an HMR according to their GP or community pharmacist.

4 Discussion

Community nursing services play a vital role in helping frail older people to remain living in their own homes. This is the first study to quantify and describe medicines management support and medication-related problems in a representative sample of older people referred to a CNS. It found that CNS clients had a very high prevalence of risk-factors for medication-related problems, including multiple co-morbidities, cognitive impairment, polypharmacy and use of medicines associated with heightened risk. CNS clients used a median of ten medicines, which is higher than the average for community-dwelling older people [23].

In the first week of care most clients were visited on at least 5 days, mainly to administer medicines. In the last week of care, the number of visits was slightly lower and the most common form of support was monitoring medicine-taking. This may reflect the fact that some clients regained independence or semi-independence, or that some of the sickest and frailest individuals, with intensive care needs, were discharged to residential care or died.

The most common form of medication authorisation used by the CNS was medicine lists provided by GPs (usually summaries printed from GPs’ electronic patient records). Medication administration charts were infrequently used, and in some cases multiple medication authorisations were used concurrently. Reliance on GP medicine lists, letters from GPs and specialists and multiple medication authorisations stems from difficulty accessing GPs to obtain and maintain medication charts in the community setting. However, use of these types of authorisation and multiple authorisations is associated with risk of medication errors. It has been reported in several studies that GP medicine lists have a high rate of errors and discrepancies, for a variety of reasons including that the GP is often not the only prescriber and because patient records are not always updated when there are dose-changes and medicines ceased [9, 24, 25]. There were 26 medication errors related to discrepancies between medication authorisations and clients’ medicines (usually pharmacy-packed dose administration aids [DAAs]), which may reflect inaccurate medication authorisations and/or deficiencies in interdisciplinary communication (e.g. GP or other prescriber failing to notify the pharmacy of a medicine change for a DAA client, or GP being unaware of a medicine change initiated by another prescriber).

Multi-compartment DAAs were used by nearly 50 % of CNS clients. Whilst these may simplify medicines management for some older people, they can also increase the cost and complexity of medicines management and there is evidence that they are sometimes used unnecessarily [12, 26]. In this study almost half of the clients who used a DAA were receiving CNS visits 7 days a week, and almost one quarter had their DAA stored in a locked box. It is likely that some of these clients could have been managed without a DAA since they were not self-administering their medicines.

Medication errors were prevalent, with 41 % clients having one or more error identified. Almost three quarters resulted from clients (or carers) missing doses or taking medicines incorrectly. It is not surprising that client/carer errors were common given that CNS clients were older people with functional and/or cognitive decline who were referred for medicines management support, and many continued to have some involvement in taking their medicines (since the CNS could usually visit only once a day and medicines often needed to be taken at other times). However, it is also possible that healthcare providers and their systems contributed to some of the errors attributed to clients. For example, failure to simplify unnecessarily complex medication regimens or to choose the simplest dose-forms sometimes contributed to client errors. It is common practice for CNS nurses to set out the evening doses for clients when they visit in the morning, in order to avoid multiple daily visits, and this practice was sometimes associated with missed doses when the client forgot to take those medicines.

Medication errors caused by CNS staff were uncommon, however this is likely to be an underestimate because these were difficult to detect using retrospective methodology (which was largely reliant on CNS staff identifying and documenting such errors) and with low usage of medication administration charts. In hospitals and residential care settings, using medication chart audits and direct observation of staff administering medicines, much higher error rates have been reported [27, 28].

Missing the occasional dose of a medicine is unlikely to be clinically significant for most medicines, so whilst missed doses were the most common error, many were of minimal clinical importance. However, some errors had potential to cause harm, such as clients double-dosing, often due to confusion associated with the use of DAAs, clients taking an incorrect dose (including cases involving insulin, warfarin and prednisolone), clients potentially receiving incorrect medicines or doses as a result of inaccurate medicine lists, inter-professional communication failures, prescribing errors or dispensing errors and running out of medicines. One-third of errors involved medicines associated with moderate or high risk of AMEs if administered incorrectly.

AMEs requiring medical attention were identified in 13 % of CNS clients, including medication-related hospital admissions in 9 % of clients. This may be an underestimate, as identification of AMEs relied on CNS documentation. It is possible that some AMEs were not recognised or documented by CNS nurses. A majority of AMEs were considered to be potentially preventable, which is consistent with studies in other populations [29, 30].

The most common cause of AMEs was prescribing problems (Table 5). This, plus the high number of medication errors, and in particular errors related to discrepancies between medication authorisations and pharmacy-packed DAAs, suggests that CNS clients could benefit from better interdisciplinary collaboration. Interdisciplinary collaboration is needed to enable a ‘best possible medication history’ and medication reconciliation [31] to occur on admission to the CNS (in order to ensure that the correct medicine regimen is implemented and all members of the healthcare team have access to the same medicine list) [6, 12], to increase the use of medication administration charts (which enable clear documentation of medication administration and improve medication safety), and to facilitate interdisciplinary medication reviews. Despite CNS clients’ high risk of AMEs, and eligibility for government-funded interdisciplinary care services, there was little evidence of formal interdisciplinary collaboration in relation to medicines management.

Interdisciplinary medication reviews such as HMR have been shown to identify and address medicine discrepancies, medication-related problems and inappropriate prescribing, simplify medication regimens and reduce the risk of AMEs [6, 11, 32, 33, 34, 35]. The CNS involved in this study, like most CNSs, does not employ its own pharmacists or medical practitioners, so the only way for an interdisciplinary medication review to occur is if the clients’ GP initiates an HMR (nurses are not able to initiate government-funded HMRs). The low use of HMR in this cohort is consistent with previous Australian studies in high-risk groups such as people referred to Aged Care Assessment Teams or residing in supported accommodation [34, 36]. Efforts to increase the uptake of HMRs, even in high-risk groups such as CNS clients, have had limited success [34, 37], suggesting that alternative methods to facilitate interdisciplinary medicines management are needed. One option is for the CNS to employ clinical pharmacists to work with its nurses to undertake medication reconciliation and medicines reviews, and liaise with clients’ GPs and community pharmacists. A pilot study exploring the role of clinical pharmacists in a CNS is currently underway [38].

A limitation of our study was that it included only one metropolitan CNS. Further studies are warranted to determine the extent to which these findings are generalisable to other CNSs, in particular in rural and regional areas. Retrospective methodology may have led to underestimation of medicine use, medication errors, AMEs and interdisciplinary teamwork. A strength of the study was random selection of subjects to obtain a sample representative of the older people referred for medicines support. Another strength was review of clients’ complete CNS records, including nursing progress notes, to extract data, which is likely to have improved detection of errors and ADRs compared with reliance on spontaneous voluntary reporting by nurses.

Although there has been little previous Australian research in the home nursing setting, research conducted internationally suggests that many of these issues are not unique to Australia. Studies from other countries (mainly the USA) have reported that home nursing clients often have multiple medicines-related risk factors (including polypharmacy, multiple healthcare providers, poor communication between providers and outdated medicine lists) leading to medication errors and AMEs [8, 9, 10, 39, 40, 41]. No Australian or international study has previously recruited a similar random sample and reported the type of medicines management support provided, so it is not possible to compare this data with other studies.

5 Conclusion

Older people referred to a CNS for medicines management support were a frail group of people with multiple risk-factors for AMEs. They received intensive medicines management support, often over a prolonged period. There was minimal formal interdisciplinary collaboration and infrequent medication review. Medication errors and AMEs were common. There is a need to develop and test strategies to improve medication safety for CNS clients.

Notes

Acknowledgments

The authors thank Ms Kira Harvey, Ms Ann Johnson, A/Prof Susan Koch, Ms Denise van den Bosch, Ms Barbara Petrie and Mr Neil Petrie for their assistance with this study.

Author contributions

RAE, CB and CYL conceived and designed the study. All authors contributed to data collection. CYL and RAE performed the data analyses, with input from all authors. RAE and CYL prepared the manuscript. All authors reviewed drafts and approved the final manuscript.

Compliance with Ethical Standards

Ethical approval

The study was approved by the Royal District Nursing Service and Monash University Human Research Ethics Committees.

Conflict of interest

Rohan Elliott, Cik Yin Lee, Christine Beanland, Krishna Vakil and Dianne Goeman declare that they have no conflicts of interest.

Funding

No financial assistance was received for the conduct of the study or preparation of the manuscript.

Supplementary material

40801_2016_65_MOESM1_ESM.doc (56 kb)
Supplementary material 1 (DOC 56 kb)

References

  1. 1.
    Australian Bureau of Statistics. 3101.0—Australian Demographic Statistics, Jun 2013.Google Scholar
  2. 2.
    Australian Institute of Health and Welfare. Residential aged care in Australia 2010–11: a statistical overview. Aged care statistics series no. 36. Cat. no. AGE 68. Canberra: AIHW; 2012.Google Scholar
  3. 3.
    Wise J. Polypharmacy: a necessary evil. BMJ. 2013;347:f7033. doi: 10.1136/bmj.f7033.CrossRefPubMedGoogle Scholar
  4. 4.
    Kemp LA, Harris E, Comino EJ. Changes in community nursing in Australia: 1995–2000. J Adv Nurs. 2005;49(3):307–14.CrossRefPubMedGoogle Scholar
  5. 5.
    Royal District Nursing Service. Summary of RDNS medication visits 2011. Internal data report; 2012.Google Scholar
  6. 6.
    Feldman PH, Totten AM, Foust J, et al. Medication management: evidence brief. Center for Home Care Policy and Research. Home Healthc Nurse. 2009;27(6):379–86.CrossRefPubMedGoogle Scholar
  7. 7.
    Johnson M, Griffiths R, Piper M, Langdon R. Risk factors for an untoward medication event among elders in community-based nursing caseloads in Australia. Public Health Nurs. 2005;22(1):36–44.CrossRefPubMedGoogle Scholar
  8. 8.
    Flaherty JH, Perry HM 3rd, Lynchard GS, Morley JE. Polypharmacy and hospitalization among older home care patients. J Gerontol Ser A Biol Sci Med Sci. 2000;55(10):M554–9.CrossRefGoogle Scholar
  9. 9.
    Ellenbecker CH, Frazier SC, Verney S. Nurses’ observations and experiences of problems and adverse effects of medication management in home care. Geriatr Nurs. 2004;25(3):164–70.CrossRefPubMedGoogle Scholar
  10. 10.
    Gusdal AK, Beckman C, Wahlström R, Törnkvist L. District nurses’ use for an assessment tool in their daily work with elderly patients’ medication management. Scand J Public Health. 2011;39(4):354–60.CrossRefPubMedGoogle Scholar
  11. 11.
    Ellenbecker CH, Samia L, Cushman MJ, Alster K. Chapter 13: patient safety and quality in home health care. In: Hughes RG, editors. Patient safety and quality: an evidence-based handbook for nurses. Rockville MD; 2008.Google Scholar
  12. 12.
    Mager DR. Medication errors and the home care patient. Home Healthc Nurse. 2007;25(3):151–5.CrossRefPubMedGoogle Scholar
  13. 13.
    Elliott RA, Booth JC. Problems with medicine use in older Australians: a review of recent literature. J Pharm Pract Res. 2014;44:258–71.CrossRefGoogle Scholar
  14. 14.
    Griffiths R, Johnson M, Piper M, Langdon R. A nursing intervention for the quality use of medicines by elderly community clients. Int J Nurs Pract. 2004;10(4):166–76.CrossRefPubMedGoogle Scholar
  15. 15.
    While C, Duane F, Beanland C, Koch S. Medication management: the perspectives of people with dementia and family carers. Dementia. 2013;12:734–50.CrossRefPubMedGoogle Scholar
  16. 16.
    While C, Duane F, Beanland C, Koch S. Self management of medicines by older people in the community: a person-centred guide to assessment. Melbourne: RDNS Helen Macpherson Smith Institute of Community Health. ISBN: 978-0-9806380-5-9. 2011.Google Scholar
  17. 17.
    Duane F, While C, Beanland C, Koch S. Making medicines manageable: a culturally and linguistically diverse perspective. Melbourne: RDNS Helen Macpherson Smith Institute of Community Health. ISBN: 978-0-9806380-6-6. 2011.Google Scholar
  18. 18.
    Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol. 1994;47(11):1245–51.CrossRefPubMedGoogle Scholar
  19. 19.
    Hallas J, Harvald B, Gram LF, et al. Drug related hospital admissions: the role of definitions and intensity of data collection, and the possibility of prevention. J Intern Med. 1990;228(2):83–90.CrossRefPubMedGoogle Scholar
  20. 20.
    Howard RL, Avery AJ, Howard PD, Partridge M. Investigation into the reasons for preventable drug related admissions to a medical admissions unit: observational study. Qual Saf Health Care. 2003;12(4):280–5.CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Pearson TF, Pittman DG, Longley JM, Grapes ZT, Vigliotti DJ, Mullis SR. Factors associated with preventable adverse drug reactions. Am J Hosp Pharm. 1994;51(18):2268–72.PubMedGoogle Scholar
  22. 22.
    Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm. 1990;47(3):533–43.PubMedGoogle Scholar
  23. 23.
    Morgan TK, Williamson M, Pirotta M, Stewart K, Myers SP, Barnes J. A national census of medicines use: a 24-hour snapshot of Australians aged 50 years and older. Med J Aust. 2012;196(1):50–3.CrossRefPubMedGoogle Scholar
  24. 24.
    Tse J, You W. How accurate is the electronic health record? A pilot study evaluating information accuracy in a primary care setting. Stud Health Technol Inform. 2011;168:158–64.PubMedGoogle Scholar
  25. 25.
    Taylor S, Welch S, Harding A, et al. Accuracy of general practitioner medication histories for patients presenting to the emergency department. Aust Fam Physician. 2014;43(10):728.PubMedGoogle Scholar
  26. 26.
    Elliott RA. Appropriate use of dose administration aids. Aust Prescriber. 2014;37:46–50.CrossRefGoogle Scholar
  27. 27.
    Barber ND, Alldred DP, Raynor DK, et al. Care homes’ use of medicines study: prevalence, causes and potential harm of medication errors in care homes for older people. Qual Saf Health Care. 2009;18(5):341–6.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Keers RN, Williams SD, Cooke J, Ashcroft DM. Causes of medication administration errors in hospitals: a systematic review of quantitative and qualitative evidence. Drug Saf. 2013;36(11):1045–67.CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Chan M, Nicklason F, Vial JH. Adverse drug events as a cause of hospital admission in the elderly. Intern Med J. 2001;31(4):199–205.CrossRefPubMedGoogle Scholar
  30. 30.
    Phillips AL, Nigro O, Macolino KA, et al. Hospital admissions caused by adverse drug events: an Australian prospective study. Aust Health Rev. 2014;38(1):51–7.CrossRefPubMedGoogle Scholar
  31. 31.
    Duguid M. The importance of medication reconciliation for patients and practitioners. Aust Prescriber. 2012;35:515–9.CrossRefGoogle Scholar
  32. 32.
    Hatah E, Braund R, Tordoff J, Duffull SB. A systematic review and meta-analysis of pharmacist-led fee-for-services medication review. Br J Clin Pharmacol. 2014;77(1):102–15.CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Jokanovic N, Tan ECK, van den Bosch D, Kirkpatrick CM, Dooley MJ, Bell JS. Clinical medication review in Australia: a systematic review. Res Soc Adm Pharm. doi: 10.1016/j.sapharm.2015.06.007
  34. 34.
    Elliott RA, Martinac G, Campbell S, Thorn J, Woodward MC. Pharmacist-led medication review to identify medication-related problems in older people referred to an Aged Care Assessment Team: a randomized comparative study. Drugs Aging. 2012;29(7):593–605.CrossRefPubMedGoogle Scholar
  35. 35.
    Morrison C, MacRae Y. Promoting safer use of high-risk pharmacotherapy: impact of pharmacist-led targeted medication reviews. Drugs-Real World Outcomes. 2015;2:261–71.CrossRefGoogle Scholar
  36. 36.
    Lee CY, George J, Elliott RA, Chapman C, Stewart K. Exploring medication risk among older residents in supported residential services: a cross-sectional study. J Pharm Pract Res. 2011;41:98–101.CrossRefGoogle Scholar
  37. 37.
    Kyle G, Nissen LM. A community nurse referral system for HMRs: can it work? Aust Pharm. 2006;25:326–31.Google Scholar
  38. 38.
    Lee CY, Beanland C, Goeman D, Koch S, Elliott RA. Enhancing medication safety for older people receiving medication support from a community nursing service [abstract]. Paper presented at: Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists-British Pharmacological Society Joint Scientific Meeting 2015, Hong Kong.Google Scholar
  39. 39.
    Meredith S, Feldman PH, Frey D, et al. Possible medication errors in home healthcare patients. J Am Geriatr Soc. 2001;49(6):719–24.CrossRefPubMedGoogle Scholar
  40. 40.
    Gray SL, Mahoney JE, Blough DK. Adverse drug events in elderly patients receiving home health services following hospital discharge. Ann Pharmacother. 1999;33(11):1147–53.CrossRefPubMedGoogle Scholar
  41. 41.
    Gray SL, Mahoney JE, Blough DK. Medication adherence in elderly patients receiving home health services following hospital discharge. Ann Pharmacother. 2001;35(5):539–45.CrossRefPubMedGoogle Scholar
  42. 42.
    Institute for Safe Medication Practices. ISMP list of high-alert medications in Community/Ambulatory Healthcare. Philadelphia: Institute for Safe Medication Practices; 2011.Google Scholar

Copyright information

© The Author(s) 2016

Open AccessThis article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Authors and Affiliations

  • Rohan A. Elliott
    • 1
    • 2
  • Cik Yin Lee
    • 1
    • 3
  • Christine Beanland
    • 3
  • Krishna Vakil
    • 1
  • Dianne Goeman
    • 3
    • 4
  1. 1.Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical SciencesMonash UniversityParkvilleAustralia
  2. 2.Pharmacy DepartmentAustin HealthHeidelberg WestAustralia
  3. 3.RDNS Institute, Royal District Nursing ServiceSt KildaAustralia
  4. 4.Central Clinical School, Faculty of Medicine, Nursing and Health SciencesMonash UniversityPrahranAustralia

Personalised recommendations